531681
AMERISE
Start SIP
Invest Now
Start SIP in AMERISE
Performance
- Low
- ₹1
- High
- ₹1
- 52 Week Low
- ₹1
- 52 Week High
- ₹1
- Open Price₹1
- Previous Close₹1
- Volume108,393
Investment Returns
- Over 1 Month + 3.23%
- Over 3 Month -3.03%
- Over 6 Month -24.71%
- Over 1 Year -51.52%
Smart Investing Starts Here Start SIP with Amerise Biosciences for Steady Growth!
Amerise Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 107
- PEG Ratio
- 0.8
- Market Cap Cr
- 4
- P/B Ratio
- 0.8
- Average True Range
- 0.04
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0
- RSI
- 55.66
- MFI
- 48.68
Amerise Biosciences Financials
Amerise Biosciences Technicals
EMA & SMA
Current Price
₹0.64
0
(0%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹0.62
- 50 Day
- ₹0.63
- 100 Day
- ₹0.66
- 200 Day
- ₹0.73
Resistance and Support
0.61
- R3 0.85
- R2 0.76
- R1 0.70
- S1 0.55
- S2 0.46
- S3 0.40
Amerise Biosciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-05 | Quarterly Results | |
| 2025-07-24 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-03 | Quarterly Results & Others | Inter-alia, to consider 1. Appointment of Mr. Kelash Bunkar as Director of the Company. 2. Resignation of Mr. Niraj Vaghela from directorship of the company. 3.Other business matters. |
| 2024-10-22 | Quarterly Results |
Amerise Biosciences F&O
About Amerise Biosciences
- NSE Symbol
- AMERISE
- BSE Symbol
- 531681
- ISIN
- INE673C01020
Similar Stocks to Amerise Biosciences
Amerise Biosciences FAQs
Amerise Biosciences share price is ₹0 As on 27 December, 2025 | 01:24
The Market Cap of Amerise Biosciences is ₹4.2 Cr As on 27 December, 2025 | 01:24
The P/E ratio of Amerise Biosciences is 107 As on 27 December, 2025 | 01:24
The PB ratio of Amerise Biosciences is 0.8 As on 27 December, 2025 | 01:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.